Switching from Prozac 40 mg to Wellbutrin XL 150 mg
Due to fluoxetine's exceptionally long half-life (4-6 days for the parent drug, 4-16 days for its active metabolite), you can stop Prozac 40 mg abruptly and start Wellbutrin XL 150 mg the next day without a washout period or cross-taper. 1
Switching Strategy
Direct Switch (Recommended)
- Stop fluoxetine 40 mg immediately
- Start bupropion XL 150 mg the following morning 2
- No tapering of fluoxetine is required due to its self-tapering pharmacokinetic profile 1
- No washout period needed between medications
Rationale for Direct Switch
Fluoxetine's uniquely long elimination half-life creates a natural, gradual decline in drug levels over 4-6 weeks after discontinuation 1. This built-in taper eliminates the need for:
- Dose reduction schedules
- Cross-tapering protocols
- Extended washout periods
The overlapping presence of fluoxetine during bupropion initiation does not create safety concerns, as these medications work through different mechanisms (SSRI vs. norepinephrine-dopamine reuptake inhibitor) and do not have significant pharmacodynamic interactions 3.
Bupropion Dosing After Switch
Start at 150 mg once daily in the morning 2
After 4 days, you may increase to 300 mg once daily if clinically indicated, though 150 mg may be sufficient initially given the patient is switching (not treatment-naive) 2.
Critical Safety Considerations
Seizure Risk
- Bupropion is contraindicated in patients with seizure disorders 3
- Risk increases with doses above 300 mg/day or rapid dose escalation 2
- Screen for: history of seizures, eating disorders (bulimia/anorexia), abrupt alcohol/benzodiazepine discontinuation, brain metastases, or stroke 4
Activation/Agitation
- Bupropion is "activating" and may worsen agitation or insomnia 3
- Do not use in patients with severe agitation or anxiety 3
- If insomnia develops, ensure the dose is taken before 3 PM 3
Monitoring Schedule
Begin monitoring within 1-2 weeks of the switch 5:
- Assess for worsening depression, suicidal ideation, agitation, or unusual behavioral changes
- Monitor treatment response and adverse effects
- Evaluate need for dose adjustment at 4 days (earliest) to 1 week
Expected Timeline
- Weeks 1-2: Fluoxetine levels declining while bupropion reaches steady state
- Weeks 2-4: Therapeutic assessment period; bupropion may show "rapid improvement of energy level" 3
- Week 6-8: Full therapeutic trial completed; modify treatment if inadequate response 5
Common Pitfalls to Avoid
- Do not taper fluoxetine - its long half-life makes this unnecessary and delays effective treatment 1
- Do not exceed 300 mg/day of bupropion XL without careful consideration of seizure risk 2
- Do not crush, divide, or chew Wellbutrin XL tablets - must be swallowed whole 2
- Do not combine with MAOIs - requires 14-day washout period 2
Adverse Effects to Anticipate
Bupropion has a significantly lower rate of sexual dysfunction compared to fluoxetine (a major advantage of this switch) 5. Common side effects include:
- Insomnia (dose before 3 PM to minimize) 3
- Headache, nausea (generally mild) 5
- Activation/restlessness (may be therapeutic for apathetic depression) 3
When to Reassess
If no adequate response by 6-8 weeks, modify treatment 5. Options include:
- Increasing bupropion to 300 mg daily (if tolerated and no contraindications)
- Switching to a different antidepressant
- Adding augmentation therapy
Approximately 60% of patients who fail fluoxetine respond to bupropion, with 30-35% achieving full remission 6.